Deirdre B. Hoban
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Nerve injury and regeneration, Pluripotent Stem Cells Research, Parkinson's Disease Mechanisms and Treatments, Neurogenesis and neuroplasticity mechanisms, Mesenchymal stem cell research
Most-Cited Works
- → Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD(2023)122 cited
- → Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson’s disease(2020)110 cited
- → Further characterisation of the LPS model of Parkinson’s disease: A comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat(2012)109 cited
- → hESC-Derived Dopaminergic Transplants Integrate into Basal Ganglia Circuitry in a Preclinical Model of Parkinson’s Disease(2019)96 cited
- → GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson’s disease(2015)91 cited
- → The reduction in immunogenicity of neurotrophin overexpressing stem cells after intra-striatal transplantation by encapsulation in an in situ gelling collagen hydrogel(2013)80 cited
- → Target‐specific forebrain projections and appropriate synaptic inputs of hESC‐derived dopamine neurons grafted to the midbrain of parkinsonian rats(2018)65 cited
- → Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD(2020)57 cited
- → Kinetics of thermally induced heat shock protein 27 and 70 expression by bone marrow‐derived mesenchymal stem cells(2012)44 cited
- → Fibrin-Based Microsphere Reservoirs for Delivery of Neurotrophic Factors to the Brain(2015)33 cited